Navigation Links
MCC Announces: Dr. Jean Mulinde, CDER, FDA Confirmed Speaker at Clinical Trial Risk and Performance Management Summit, Nov. 14-15, 2018, Princeton, NJ
Date:11/3/2018

Come to Princeton Nov. 14 and 15 for the first-ever Metrics Champion Consortium Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA will be presenting on using data to assess and manage risk, monitor safety and ensure data reliability.

What should clinical research industry stakeholders keep in mind when implementing and managing risk-based quality management programs?

How is the FDA using data to quantify risk to determine where to conduct site inspections?

The Clinical Trial Risk and Performance Management Summit and Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, CDER, FDA have the answers.

Come to Princeton Nov. 14 and 15 for the first-ever Metrics Champion Consortium Summit. This will be an exclusive gathering of the top minds in trial performance metrics, spearheaded by MCC Executive Director Linda Sullivan. The keynote speaker will be Ken Getz, Associate Professor and Director, CSDD, Tufts University and Founder and Board Chair, CISCRP, clinical trials guru, founder of CenterWatch and an MCC partner. Plan on attending this must-see presentation: Next Gen Benchmarking in Biopharma by Linda Martin, President and Founder, The KMR Group.

The roster of experts will guide attendees through the issues that are top of mind in clinical trials metrics today:

  •      How is ICH-E6(R2) changing what needs to be measured? What are global regulators looking for?
  • How do metrics influence behavior? Is it rewarding firefighting or preventing problems? Does staff have the critical thinking skills needed to root out what needs to be changed?
  • Centralized monitoring. How is industry approaching key risk indicators and quality tolerance limits?
  • Getting to the root of the problem. Pros and cons of traditional analytic approaches: Is there a better way?
  • Predictive analytics. The next-level key to success. But how to get there?

The Clinical Trial Risk and Performance Management Summit is interactive. Attendees roll up their sleeves with speakers and fellow attendees as they tackle case studies that will bring clarity to the metrics process — and provide needed answers.

Who Will Benefit:

This event is designed for professionals from pharmaceutical, biotechnology and medical device companies; CROs; and other clinical service providers who have responsibilities in the following areas:

  • Clinical Operations/Management/ Research/Development
  • Clinical Outsourcing/Vendor Management/Third-Party Management
  • Clinical/Project Operations
  • Performance Analytics/Management/Reporting
  • Metric Reporting/Visualization
  • Quality Management/Clinical Quality Management
  • Compliance/Clinical Compliance/ Regulatory Compliance
  • Monitoring/Site Management/Study Management
  • Clinical Risk Assessment
  • Centralized Monitoring / Risk-based Monitoring
  • Good Clinical Practices
  • Clinical Process Optimization
  • Vendor Oversight

Conference Details
Clinical Trial Risk and Performance Management Summit
**Presented by Metrics Champion Consortium a Division of CenterWatch **
Nov. 14-15, 2018 – Princeton, NJ
http://www.fdanews.com/ctriskperformancemngmntsummit

Tuition:
Regular Pricing: $1,797
Significant team discounts are available.

Easy Ways to Register
Online: http://www.fdanews.com/ctriskperformancemngmntsummit
By phone: 888-838-5578 or 703-538-7600

About MCC
Leading the drug-development enterprise in the adoption and utilization of standardized metrics and benchmarks to drive performance improvement. Founded in 2006, MCC is the leading industry association dedicated to the development of standardized performance metrics to improve clinical trials. MCC provides the collaborative environment for biopharmaceutical and device sponsors, service providers and sites to improve clinical-trial development through use of MCC standardized performance metrics.

Clinical Trial Risk and Performance Management Summit
**Presented by Metrics Champion Consortium a Division of CenterWatch**
Nov. 14-15, 2018 – Princeton, NJ
http://www.fdanews.com/ctriskperformancemngmntsummit

Read the full story at https://www.prweb.com/releases/mcc_announces_dr_jean_mulinde_cder_fda_confirmed_speaker_at_clinical_trial_risk_and_performance_management_summit_nov_14_15_2018_princeton_nj/prweb15885737.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology technology :

1. SonaCare Medical Announces: Two Independent Physicians Launch HIFU Program out of Same Facility
2. Telomere Biosciences Announces: TELO-20 for Dogs, the Worlds First Telomere-Lengthening Supplement for Dogs, to Promote Healthy Aging and Longevity
3. Telomere Biosciences Announces: TELO-100 with T-Activator 150, a Breakthrough in Telomere Science and Age Management
4. First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test
5. Anisina Confirmed as Effective Anti-Cancer Agent in Animal Studies
6. True Flow of the HeartAssist5® confirmed by LVAD Implant Center Ramp Studies
7. Potential of Anisina to Become Major New Chemotherapy Confirmed by Coda Study
8. Established in Plants, Now Confirmed in Animals — Chromatin in Daughter Cells is Asymmetrical in All Eukaryotes
9. Speakers Confirmed for BSMA SCM Annual Conference Oct 23-24, 2014
10. BIOPHARMA Executives Summit, 6th BSMA Annual Conference: Look Who Is Confirmed to Speak
11. Trenton High School Confirmed with Bed Bugs, Help How to Kill Bed Bugs More Safely Introduced by My Cleaning Products to Parents and Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/9/2019)... ... April 09, 2019 , ... USDM Life ... of life sciences organizations to accelerate innovation and maximize productivity, announces that nearly ... past 12 months. , USDM’s Cloud Assurance is a managed subscription ...
(Date:4/9/2019)... MILWAUKEE (PRWEB) , ... April 09, 2019 , ... The ... five incoming members of the Society's leadership team, including a new addition to the ... elected five of their peers to join the Society's leadership team for a three-year ...
(Date:4/8/2019)... SAN FRANCISCO (PRWEB) , ... April 08, 2019 , ... ... to accredited investors a $15 million preferred equity investment in the privately held pharmaceutical ... dysfunction. Its leading drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and ...
(Date:4/4/2019)... ... 02, 2019 , ... Biomeme, Inc. , a leading ... field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called Franklin ... Franklin, an English chemist and X-ray crystallographer who made significant contributions to the ...
Breaking Biology Technology:
(Date:4/1/2019)... ... April 01, 2019 , ... uBiome announces the issue ... by the US Patent and Trademark Office on January 1, 2019 with a ... collaborators Dr. Zachary Apte, Dr. Daniel Almonacid, Dr. Jessica Richman, and Dr. ...
(Date:3/29/2019)... ... March 28, 2019 , ... In ... new PT programme entirely dedicated to Chinese biobanks was launched in July 2018, ... (ISBER) and the Biobank Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot ...
(Date:3/29/2019)... ... March 29, 2019 , ... GenCure ... new multi-product cell therapy facility. The new facility, which will anchor the VelocityTX ... state of the art manufacturing capabilities to support clinical cell therapy trials. GenCure ...
Breaking Biology News(10 mins):